Home
-
What We Do
We are experts in medical chart review studies for health economics and outcomes research, and our clients include the world's leading pharmaceutical and biotech companies. Our method of data collection, which we call Targeted Abstraction Process or TAP™, is different than other methods of data collection. TAP™ is a scientific, rigorous, and efficient process that uses physicians as study investigators for chart data abstraction and validation. We have unparalleled experience across numerous therapeutic areas and treatment settings involving patients, physicians, and institutions in the US and global markets. Our studies include large, geographically representative samples of target populations that yield data with high-level detail and accuracy, leading to greater confidence in business planning decisions.
Read more > -
How We Do It
We work collaboratively with our clients to define research objectives and recommend research solutions designed to deliver targeted, insightful results. We use our unique Targeted Abstraction Process, or TAP™, to generate comprehensive, robust datasets that have been validated against the source document. Using our core competencies, we can integrate qualitative and quantitative research techniques into medical chart reviews to collect information on physician and patient attitudes and perceptions so as to better understand factors impacting treatment decisions, clinical outcomes, and resource use. Our project teams are highly trained and dedicated professionals who are available around the clock to manage projects and respond to client inquiries.
Read more > -
Now an RTI Health
Solutions business
Read more >
We are pleased to announce that we have joined with RTI Health Solutions and can now offer an extensive portfolio of research and consulting services. In addition to the real-world evidence you need to demonstrate value to all stakeholders—including regulators, payers, providers, and patients—our colleagues at RTI-HS can help you with every aspect of developing a successful evidence-generation program. We can assemble a collaborative team of experts in health economics, patient-centered outcomes research, market access, epidemiology, and clinical research services that are well-versed in using appropriate methodologies and data sources. Partner with us to generate a strategic approach to your drug or medical device development activities throughout your product’s lifecycle.
